𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Five-year results of the treatment of 23 patients with immunoproliferative small intestinal disease : A Turkish experience

✍ Scribed by Hakan Akbulut; Irfan Soykan; Fahri Yakaryilmaz; Fikri Icli; Fehmi Aksoy; Serap Haznedaroglu; Safa Yildirim

Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
549 KB
Volume
80
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis

BACKGROUND.

Currently, there is no agreement regarding optimal treatment strate-

πŸ“œ SIMILAR VOLUMES

Retardation of joint damage in patients
Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: Five-year experience from the FIN-RACo study
✍ Markku Korpela; Leena Laasonen; Pekka Hannonen; Hannu Kautiainen; Marjatta Leiri πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 111 KB πŸ‘ 2 views

## Abstract ## Objective To evaluate the long‐term frequency of disease remissions and the progression of joint damage in patients with early rheumatoid arthritis (RA) who were initially randomized to 2 years of treatment with either a combination of 3 disease‐modifying antirheumatic drugs (DMARDs

Adjuvant immunotherapy treatment of rena
Adjuvant immunotherapy treatment of renal carcinoma patients with autologous tumor cells and Bacillus Calmette-Guèrin: Five-year results of a prospective randomized study
✍ Enzo Galligioni; Michele Quaia; Alberto Merlo; Antonino Carbone; Antonella Spada πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 613 KB

## BACKGROUND. Active specific immunotherapy (ASI) is a strategy that attempts to boost the host's immune response specifically against its own tumor. The purpose of this study was to investigate the effect of adjuvant AS1 in patients with renal carcinoma. ## METHODS. Of 120 consecutive patient